Skip to content
  1. Stocks
  2. Cement & Materials
  3. Vineet Laboratories

Vineet Laboratories share price

NSE: VINEETLABCement & MaterialsChemicals

₹38.24
(−0.34%)
NSE close · 22 Oct 2026
Vineet Laboratories closed at ₹38.24 on 22 Oct 2026, up 7.5% from ₹35.58 on 3 Oct 2025
3 Oct 2025Closing high ₹42.70 (24 Apr 2026) · closing low ₹28.96 (30 Mar 2026)22 Oct 2026

Vineet Laboratories at a glance

Vineet Laboratories (NSE: VINEETLAB) closed at ₹38.24 on 22 Oct 2026, down 0.34% on the day. With a market capitalisation of ₹73 Cr, it ranks 2838th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Chemicals.

Its return on equity was −137.8% in FY25. Over the past year the share price has risen 11.6%. Its 52-week range is ₹27.96 (9 Mar 2026) to ₹43.50 (27 Apr 2026); the last close is 12.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹116 Cr (+13.2% year on year) and net profit −₹0 Cr (−110.2%), on a consolidated basis. Promoters held 5.98% of the company as of 30 Jun 2026.

Key numbers

Market cap
₹73 CrRank 2838 on NSE
Price to book
1.92×FY25
EPS (TTM)
₹0.03to Q4 FY26
ROE
−137.8%FY25
ROCE
−83.4%FY25
Debt to equity
2.73FY25
Net profit margin
−26.9%FY25
Book value / share
₹15.89FY25
52-week high
₹43.5027 Apr 2026
52-week low
₹27.969 Mar 2026
1-year return
+11.6%
RSI (14-day)
54.9

Returns to 22 Oct 2026

Period1 day1 week1 month3 months1 year
Price change−0.34%−0.7%+6.8%+3.2%+11.6%

Vineet Laboratories quarterly results

₹ crore unless stated · consolidated · newest on the right
QuarterQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue₹101 Cr₹89 Cr₹85 Cr₹103 Cr₹104 Cr₹65 Cr₹69 Cr₹116 Cr
Revenue YoY+75.1%+46.9%+23.8%+43.1%+2.5%−27.5%−18.9%+13.2%
Net profit₹10 Cr₹3 Cr−₹1 Cr₹4 Cr₹2 Cr₹2 Cr−₹1 Cr−₹0 Cr
Net profit YoY+569.7%+61.0%−144.7%+87.0%−77.2%−38.6%—−110.2%
Net margin10.3%3.2%−0.6%4.2%2.3%2.7%−0.8%−0.4%
EPS₹0.07₹0.01₹0.00₹0.03₹0.02₹0.01₹0.00₹0.00

Vineet Laboratories financials

Annual, ₹ crore unless stated · fiscal years ending March
ItemFY21FY22FY23FY24FY25FY26
Revenue———₹259 Cr₹378 Cr₹353 Cr
Operating profit———₹9 Cr₹9 Cr₹6 Cr
Net profit———₹7 Cr₹17 Cr₹3 Cr
EPS (₹)———₹0.00₹0.00₹0.00
Total debt₹3 Cr₹2 Cr₹5 Cr₹4 Cr₹4 Cr—
Shareholders' equity₹27 Cr₹33 Cr₹34 Cr₹35 Cr₹15 Cr—

Vineet Laboratories shareholding pattern

% of shares held, by quarter end
Holder31 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 2026
Promoters35.85%29.26%15.89%12.46%5.98%5.98%
Foreign institutions————0.36%0.50%
Non-institutions64.15%70.74%84.11%87.54%93.66%93.52%

Vineet Laboratories vs peers

The listed Cement & Materials companies nearest to Vineet Laboratories by market capitalisation.

CompanyPrice1 day1 yearMarket capP/EROE
KAKATCEMKakatiya Cement Sugar & Industries₹96.40+1.47%−31.4%₹75 Cr——
TOKYOPLASTTokyo Plast International₹78.39+0.44%−38.5%₹74 Cr118.8—
EIKOEiko Lifescienc———₹74 Cr——
VINEETLABVineet Laboratories₹38.24−0.34%+11.6%₹73 Cr——
FIBERWEBFiberweb (India)₹25.35+1.16%−39.0%₹73 Cr7.3—
KHAITANLTDKhaitan (India)₹151.00+6.33%+16.2%₹72 Cr21.3—
KKALPANAINDKkalpana Ind———₹72 Cr——

Ask anything about Vineet Laboratories

Pivot answers on the live chart with evidence you can check, and tests strategies against VINEETLAB's own history. Try: “Why has VINEETLAB moved over the last three months?” · “Backtest a 50-day moving-average crossover on VINEETLAB over five years” · “Compare VINEETLAB with KAKATCEM on margins and valuation”

Start free

Frequently asked questions about Vineet Laboratories

What is the share price of Vineet Laboratories today?

Vineet Laboratories (NSE: VINEETLAB) last closed at ₹38.24 on 22 Oct 2026. Its 52-week high is ₹43.50 and its 52-week low is ₹27.96.

What is the market cap of Vineet Laboratories?

Vineet Laboratories' market capitalisation is ₹73 Cr (₹73 Cr) at the 22 Oct 2026 close, ranking 2838th among the NSE companies Pivot tracks.

What is the ROE and ROCE of Vineet Laboratories?

Return on equity was −137.8% in FY25 and return on capital employed was −83.4% in FY25 (standalone figures).

Is Vineet Laboratories a debt-free company?

No. Vineet Laboratories' debt-to-equity ratio was 2.73 in FY25, with total debt of ₹4 Cr.

What were Vineet Laboratories' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Vineet Laboratories reported revenue of ₹116 Cr, +13.2% year on year, and net profit of −₹0 Cr, −110.2% year on year.

How has Vineet Laboratories stock performed over the last year?

Vineet Laboratories' share price has risen 11.6% over the past year, +3.2% over three months and +6.8% over one month, to the 22 Oct 2026 close.

What is the shareholding pattern of Vineet Laboratories?

As of 30 Jun 2026: promoters 5.98%, foreign institutions 0.50%, non-institutions 93.52%.

Who are Vineet Laboratories' competitors?

The listed Cement & Materials companies closest to Vineet Laboratories by market cap are Kakatiya Cement Sugar & Industries, Tokyo Plast International, Eiko Lifescienc, Fiberweb (India), Khaitan (India) and Kkalpana Ind.

Is Vineet Laboratories a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Vineet Laboratories' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VINEETLAB against its own history before risking money. This is analysis, not financial advice.

Sources and method

Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.

More: all Cement & Materials stocks · companies starting with V · all NSE stocks · this page as text